H. Wilkens (Homburg/Saar, Germany), A. van der Meer (Leeuwarden, Netherlands), M. Del Donno (Benevento, BN, Italy)
Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
T. Pfeffer (Bad Nauheim, Germany)
|  |
Late Breaking Abstract - Pulmonary hypertension modifies cardiac genes myh7 and col1a1 nonreversible by training
A. Ferreira (PRESIDENTE PRUDENTE/SP, Brazil)
| |
Late Breaking Abstract - Whole exome sequencing and runs of homozygosity Identifies a Novel Mutation of DYX1C1 in Primary Ciliary Dyskinesia From a consanguineous Chinese Family
T. Guo (chang sha, China)
|  |
Late Breaking Abstract - Safety of combined pirfenidone (PFD) and nintedanib (NIN) in patients with idiopathic pulmonary fibrosis (IPF)
K. Flaherty (Pinckney, United States of America)
| |
Late Breaking Abstract - Long-term safety of pirfenidone in a real-world setting: final results from the prospective, observational PASSPORT registry
V. Cottin (Lyon, France)
| |
Late Breaking Abstract - Retrospective study to analyze role of age in the oximetry parameters of the respiratory polygraphy
G. Ernst (Buenos Aires, Argentina)
| |
Late Breaking Abstract - The miR-34a/Pdgfra interaction can be targeted to correct defective alveolarization in experimental bronchopulmonary dysplasia
J. Ruiz Camp (Giessen, Germany)
| |
Late Breaking Abstract - Actin-scavenging gelsolin: A marker of one-month lasting ventilator-demanding respiratory failure in critically ill patients
F. Holm (Brønshøj, Denmark)
| |
Late Breaking Abstract - Responder phenotyping using functional respiratory imaging (FRI) in IPF patients treated with anti-CGTG monoclonal antibody FG3019
E. Kouchakji (San Francisco, United States of America), M. Lanclus
| |
Late Breaking Abstract - New method for molecular phenotyping of noisy breathing infants
G. Slingers (Nieuwerkerken, Belgium)
| |
Late Breaking Abstract - Enhancing the antimicrobial efficacy of mesenchymal stem cells (MSCs) to combat sepsis-induced acute lung injury (ALI) using a novel combination of immune-stimulants
E. Murphy (Glasnevin, Ireland)
| |